HBK Sorce Advisory’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
1CP
NRW
KIM
HBK Sorce Advisory's BME Position: Q1 2026 in Review
HBK Sorce Advisory increased its BlackRock Health Sciences Trust (BME) stake by 6.1% in Q1 2026, buying an estimated $33K and bringing the position to 13,961 shares worth $544K. The position accounts for 0.01% of the portfolio, ranked #360.
HBK Sorce Advisory first reported a position in BME in Q2 2021 and has held it in 20 quarters since. The position peaked at $554K in Q4 2025. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.
- HBK Sorce Advisory held 13,961 shares of BlackRock Health Sciences Trust worth $544K as of Q1 2026.
- HBK Sorce Advisory bought 801 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $33K.
- BlackRock Health Sciences Trust made up 0.01% of HBK Sorce Advisory's portfolio in Q1 2026, its #360 holding.
- HBK Sorce Advisory first reported a position in BlackRock Health Sciences Trust in Q2 2021 and has held it in 20 quarters since.
- HBK Sorce Advisory's BlackRock Health Sciences Trust position peaked at $554K in Q4 2025.
- 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.
Based on HBK Sorce Advisory's 13F filing for Q1 2026, filed 11 May 2026.